497

Eaton Vance Management

Two International Place

Boston, MA  02110

(617)482-8260

www.eatonvance.com

July 2, 2012

Securities and Exchange Commission

100 F Street, NE  

Washington, DC  20549

Attn:  Office of Filings, Information & Consumer Services

Re:

Eaton Vance Growth Trust (the “Registrant”) (1933 Act File No. 002-22019)

on behalf of Eaton Vance Worldwide Health Sciences Fund (the “Fund”)

Ladies and Gentlemen:

On behalf of the Registrant and pursuant to Rule 497(e) under the Securities Act of 1933, as amended, attached for filing are exhibits containing interactive data format risk/return summary information that mirrors the risk/return summary information in a supplement dated June 21, 2012 to the Prospectus dated January 1, 2012 of the Fund.  The purpose of the filing is to submit the 497(e) filing dated June 21, 2012 in XBRL for the Fund.

If you have any questions concerning the foregoing, kindly call the undersigned at (617) 672-8509.

Very truly yours,

/s/ Deanna R. Berry

Deanna R. Berry

Assistant Vice President

XML

EATON VANCE WORLDWIDE HEALTH SCIENCES FUND
Supplement to Prospectus dated January 1, 2012

1.  The following replaces “Fees and Expenses of the Fund” under “Fund Summary”:

This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund.  You may qualify for a reduced sales charge if you invest, or agree to invest over a 13-month period, at least $50,000 in Eaton Vance Funds.  More information about these and other discounts is available from your financial intermediary and in Sales Charges beginning on page 15 of the Fund's Prospectus and page 21 of the Fund’s Statement of Additional Information.

Shareholder Fees  (fees paid directly from your investment)	Class A	Class B	Class C	Class I	Class R
Maximum Sales Charge (Load) (as a percentage of offering price)	5.75%	None	None	None	None
Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)	None	5.00%	1.00%	None	None

Annual Fund Operating Expenses (expenses you pay each year as a percentage of the value of your investment)(1)	Class A	Class B	Class C	Class I	Class R
Management Fees(2)	1.14%	1.14%	1.14%	1.14%	1.14%
Distribution and Service (12b-1) Fees	0.25%	1.00%	1.00%	n/a	0.50%
Other Expenses	0.31%	0.31%	0.31%	0.31%	0.31%
Total Annual Fund Operating Expenses	1.70%	2.45%	2.45%	1.45%	1.95%

⁽¹⁾

Expenses in the table above and the Example below reflect the expenses of the Fund and the Portfolio.

⁽²⁾

Management Fees have been restated to reflect the terms of an Amended and Restated Investment Advisory Agreement effective August 1, 2011 and assume that the new Index used for performance fee purposes was in place for the entire performance adjustment period.  The restated performance fee adjustment would have increased the effective rate of the basic investment advisory fee of 0.48% by 0.17% for the most recent fiscal year ended August 31, 2011.  Restated Management Fees also reflect a fee reduction agreement to the Management Agreement and an Amended and Restated Administrative Services Agreement, both effective May 1, 2012.  See page 9 of the Fund's Prospectus for more information about the calculation of the performance fee adjustment.

Example.  This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds.  The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods.  The Example also assumes that your investment has a 5% return each year and that the operating expenses remain the same.  Although your actual costs may be higher or lower, based on these assumptions your costs would be:

	Expenses with Redemption				Expenses without Redemption
	1 Year	3 Years	5 Years	10 Years	1 Year	3 Years	5 Years	10 Years
Class A shares	$ 738	$ 1,080	$ 1,445	$ 2,468	$ 738	$ 1,080	$ 1,445	$ 2,468
Class B shares	$ 748	$ 1,164	$ 1,506	$ 2,601	$ 248	$ 764	$ 1,306	$ 2,601
Class C shares	$ 348	$ 764	$ 1,306	$ 2,786	$ 248	$ 764	$ 1,306	$ 2,786
Class I shares	$ 148	$ 459	$ 792	$ 1,735	$ 148	$ 459	$ 792	$ 1,735
Class R shares	$ 198	$ 612	$ 1,052	$ 2,275	$ 198	$ 612	$ 1,052	$ 2,275

XML

Label

Element

Value

Risk/Return:

rr_RiskReturnAbstract

Registrant Name

dei_EntityRegistrantName

EATON VANCE GROWTH TRUST

Prospectus Date

rr_ProspectusDate

Jan. 01, 2012

Supplement [Text Block]

evgt1_SupplementTextBlock

EATON VANCE WORLDWIDE HEALTH SCIENCES FUND
Supplement to Prospectus dated January 1, 2012

1.  The following replaces “Fees and Expenses of the Fund” under “Fund Summary”:

This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund.  You may qualify for a reduced sales charge if you invest, or agree to invest over a 13-month period, at least $50,000 in Eaton Vance Funds.  More information about these and other discounts is available from your financial intermediary and in Sales Charges beginning on page 15 of the Fund's Prospectus and page 21 of the Fund’s Statement of Additional Information.

Shareholder Fees  (fees paid directly from your investment)	Class A	Class B	Class C	Class I	Class R
Maximum Sales Charge (Load) (as a percentage of offering price)	5.75%	None	None	None	None
Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)	None	5.00%	1.00%	None	None

Annual Fund Operating Expenses (expenses you pay each year as a percentage of the value of your investment)(1)	Class A	Class B	Class C	Class I	Class R
Management Fees(2)	1.14%	1.14%	1.14%	1.14%	1.14%
Distribution and Service (12b-1) Fees	0.25%	1.00%	1.00%	n/a	0.50%
Other Expenses	0.31%	0.31%	0.31%	0.31%	0.31%
Total Annual Fund Operating Expenses	1.70%	2.45%	2.45%	1.45%	1.95%

⁽¹⁾

Expenses in the table above and the Example below reflect the expenses of the Fund and the Portfolio.

⁽²⁾

Management Fees have been restated to reflect the terms of an Amended and Restated Investment Advisory Agreement effective August 1, 2011 and assume that the new Index used for performance fee purposes was in place for the entire performance adjustment period.  The restated performance fee adjustment would have increased the effective rate of the basic investment advisory fee of 0.48% by 0.17% for the most recent fiscal year ended August 31, 2011.  Restated Management Fees also reflect a fee reduction agreement to the Management Agreement and an Amended and Restated Administrative Services Agreement, both effective May 1, 2012.  See page 9 of the Fund's Prospectus for more information about the calculation of the performance fee adjustment.

Example.  This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds.  The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods.  The Example also assumes that your investment has a 5% return each year and that the operating expenses remain the same.  Although your actual costs may be higher or lower, based on these assumptions your costs would be:

	Expenses with Redemption				Expenses without Redemption
	1 Year	3 Years	5 Years	10 Years	1 Year	3 Years	5 Years	10 Years
Class A shares	$ 738	$ 1,080	$ 1,445	$ 2,468	$ 738	$ 1,080	$ 1,445	$ 2,468
Class B shares	$ 748	$ 1,164	$ 1,506	$ 2,601	$ 248	$ 764	$ 1,306	$ 2,601
Class C shares	$ 348	$ 764	$ 1,306	$ 2,786	$ 248	$ 764	$ 1,306	$ 2,786
Class I shares	$ 148	$ 459	$ 792	$ 1,735	$ 148	$ 459	$ 792	$ 1,735
Class R shares	$ 198	$ 612	$ 1,052	$ 2,275	$ 198	$ 612	$ 1,052	$ 2,275

Eaton Vance Worldwide Health Sciences Fund

Risk/Return:

rr_RiskReturnAbstract

Supplement [Text Block]

evgt1_SupplementTextBlock

EATON VANCE WORLDWIDE HEALTH SCIENCES FUND
Supplement to Prospectus dated January 1, 2012

1.  The following replaces “Fees and Expenses of the Fund” under “Fund Summary”:

This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund.  You may qualify for a reduced sales charge if you invest, or agree to invest over a 13-month period, at least $50,000 in Eaton Vance Funds.  More information about these and other discounts is available from your financial intermediary and in Sales Charges beginning on page 15 of the Fund's Prospectus and page 21 of the Fund’s Statement of Additional Information.

Shareholder Fees  (fees paid directly from your investment)	Class A	Class B	Class C	Class I	Class R
Maximum Sales Charge (Load) (as a percentage of offering price)	5.75%	None	None	None	None
Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)	None	5.00%	1.00%	None	None

Annual Fund Operating Expenses (expenses you pay each year as a percentage of the value of your investment)(1)	Class A	Class B	Class C	Class I	Class R
Management Fees(2)	1.14%	1.14%	1.14%	1.14%	1.14%
Distribution and Service (12b-1) Fees	0.25%	1.00%	1.00%	n/a	0.50%
Other Expenses	0.31%	0.31%	0.31%	0.31%	0.31%
Total Annual Fund Operating Expenses	1.70%	2.45%	2.45%	1.45%	1.95%

⁽¹⁾

Expenses in the table above and the Example below reflect the expenses of the Fund and the Portfolio.

⁽²⁾

Management Fees have been restated to reflect the terms of an Amended and Restated Investment Advisory Agreement effective August 1, 2011 and assume that the new Index used for performance fee purposes was in place for the entire performance adjustment period.  The restated performance fee adjustment would have increased the effective rate of the basic investment advisory fee of 0.48% by 0.17% for the most recent fiscal year ended August 31, 2011.  Restated Management Fees also reflect a fee reduction agreement to the Management Agreement and an Amended and Restated Administrative Services Agreement, both effective May 1, 2012.  See page 9 of the Fund's Prospectus for more information about the calculation of the performance fee adjustment.

Example.  This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds.  The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods.  The Example also assumes that your investment has a 5% return each year and that the operating expenses remain the same.  Although your actual costs may be higher or lower, based on these assumptions your costs would be:

	Expenses with Redemption				Expenses without Redemption
	1 Year	3 Years	5 Years	10 Years	1 Year	3 Years	5 Years	10 Years
Class A shares	$ 738	$ 1,080	$ 1,445	$ 2,468	$ 738	$ 1,080	$ 1,445	$ 2,468
Class B shares	$ 748	$ 1,164	$ 1,506	$ 2,601	$ 248	$ 764	$ 1,306	$ 2,601
Class C shares	$ 348	$ 764	$ 1,306	$ 2,786	$ 248	$ 764	$ 1,306	$ 2,786
Class I shares	$ 148	$ 459	$ 792	$ 1,735	$ 148	$ 459	$ 792	$ 1,735
Class R shares	$ 198	$ 612	$ 1,052	$ 2,275	$ 198	$ 612	$ 1,052	$ 2,275

Risk/Return [Heading]

rr_RiskReturnHeading

Eaton Vance Worldwide Health Sciences Fund
Supplement to Prospectus dated January 1, 2012

Expense Narrative [Text Block]

rr_ExpenseNarrativeTextBlock

This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund. You may qualify for a reduced sales charge if you invest, or agree to invest over a 13-month period, at least $50,000 in Eaton Vance Funds. More information about these and other discounts is available from your financial intermediary and in Sales Charges beginning on page 15 of the Fund's Prospectus and page 21 of the Fund’s Statement of Additional Information.

Shareholder Fees Caption [Text]

rr_ShareholderFeesCaption

Shareholder Fees  (fees paid directly from your investment)

Operating Expenses Caption [Text]

rr_OperatingExpensesCaption

Annual Fund Operating Expenses (expenses you pay each year as a percentage of the value of your investment)

Expense Breakpoint Discounts [Text]

rr_ExpenseBreakpointDiscounts

You may qualify for a reduced sales charge if you invest, or agree to invest over a 13-month period, at least $50,000 in Eaton Vance Funds. More information about these and other discounts is available from your financial intermediary and in Sales Charges beginning on page 15 of the Fund's Prospectus and page 21 of the Fund’s Statement of Additional Information.

Expense Breakpoint, Minimum Investment Required [Amount]

rr_ExpenseBreakpointMinimumInvestmentRequiredAmount

50,000

Expenses Restated to Reflect Current [Text]

rr_ExpensesRestatedToReflectCurrent

Management Fees have been restated to reflect the terms of an Amended and Restated Investment Advisory Agreement effective August 1, 2011 and assume that the new Index used for performance fee purposes was in place for the entire performance adjustment period. The restated performance fee adjustment would have increased the effective rate of the basic investment advisory fee of 0.48% by 0.17% for the most recent fiscal year ended August 31, 2011. Restated Management Fees also reflect a fee reduction agreement to the Management Agreement and an Amended and Restated Administrative Services Agreement, both effective May 1, 2012. See page 9 of the Fund's Prospectus for more information about the calculation of the performance fee adjustment.

Expense Example [Heading]

rr_ExpenseExampleHeading

Example.

Expense Example Narrative [Text Block]

rr_ExpenseExampleNarrativeTextBlock

This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the operating expenses remain the same. Although your actual costs may be higher or lower, based on these assumptions your costs would be:

Expense Example by, Year, Caption [Text]

rr_ExpenseExampleByYearCaption

Expenses with Redemption

Expense Example, No Redemption, By Year, Caption [Text]

rr_ExpenseExampleNoRedemptionByYearCaption

Expenses without Redemption

Eaton Vance Worldwide Health Sciences Fund | Class A

Risk/Return:

rr_RiskReturnAbstract

Trading Symbol

dei_TradingSymbol

ETHSX

Maximum Sales Charge (Load) (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

5.75%

Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)

rr_MaximumDeferredSalesChargeOverOfferingPrice

none

Management Fees

rr_ManagementFeesOverAssets

1.14%

^[1],[2]

Distribution and Service (12b-1) Fees

rr_DistributionAndService12b1FeesOverAssets

0.25%

^[1]

Other Expenses

rr_OtherExpensesOverAssets

0.31%

^[1]

Total Annual Fund Operating Expenses

rr_ExpensesOverAssets

1.70%

^[1]

1 Year

rr_ExpenseExampleYear01

738

3 Years

rr_ExpenseExampleYear03

1,080

5 Years

rr_ExpenseExampleYear05

1,445

10 Years

rr_ExpenseExampleYear10

2,468

1 Year

rr_ExpenseExampleNoRedemptionYear01

738

3 Years

rr_ExpenseExampleNoRedemptionYear03

1,080

5 Years

rr_ExpenseExampleNoRedemptionYear05

1,445

10 Years

rr_ExpenseExampleNoRedemptionYear10

2,468

Eaton Vance Worldwide Health Sciences Fund | Class B

Risk/Return:

rr_RiskReturnAbstract

Trading Symbol

dei_TradingSymbol

EMHSX

Maximum Sales Charge (Load) (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)

rr_MaximumDeferredSalesChargeOverOfferingPrice

5.00%

Management Fees

rr_ManagementFeesOverAssets

1.14%

^[1],[2]

Distribution and Service (12b-1) Fees

rr_DistributionAndService12b1FeesOverAssets

1.00%

^[1]

Other Expenses

rr_OtherExpensesOverAssets

0.31%

^[1]

Total Annual Fund Operating Expenses

rr_ExpensesOverAssets

2.45%

^[1]

1 Year

rr_ExpenseExampleYear01

748

3 Years

rr_ExpenseExampleYear03

1,164

5 Years

rr_ExpenseExampleYear05

1,506

10 Years

rr_ExpenseExampleYear10

2,601

1 Year

rr_ExpenseExampleNoRedemptionYear01

248

3 Years

rr_ExpenseExampleNoRedemptionYear03

764

5 Years

rr_ExpenseExampleNoRedemptionYear05

1,306

10 Years

rr_ExpenseExampleNoRedemptionYear10

2,601

Eaton Vance Worldwide Health Sciences Fund | Class C

Risk/Return:

rr_RiskReturnAbstract

Trading Symbol

dei_TradingSymbol

ECHSX

Maximum Sales Charge (Load) (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)

rr_MaximumDeferredSalesChargeOverOfferingPrice

1.00%

Management Fees

rr_ManagementFeesOverAssets

1.14%

^[1],[2]

Distribution and Service (12b-1) Fees

rr_DistributionAndService12b1FeesOverAssets

1.00%

^[1]

Other Expenses

rr_OtherExpensesOverAssets

0.31%

^[1]

Total Annual Fund Operating Expenses

rr_ExpensesOverAssets

2.45%

^[1]

1 Year

rr_ExpenseExampleYear01

348

3 Years

rr_ExpenseExampleYear03

764

5 Years

rr_ExpenseExampleYear05

1,306

10 Years

rr_ExpenseExampleYear10

2,786

1 Year

rr_ExpenseExampleNoRedemptionYear01

248

3 Years

rr_ExpenseExampleNoRedemptionYear03

764

5 Years

rr_ExpenseExampleNoRedemptionYear05

1,306

10 Years

rr_ExpenseExampleNoRedemptionYear10

2,786

Eaton Vance Worldwide Health Sciences Fund | Class I

Risk/Return:

rr_RiskReturnAbstract

Trading Symbol

dei_TradingSymbol

EIHSX

Maximum Sales Charge (Load) (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)

rr_MaximumDeferredSalesChargeOverOfferingPrice

none

Management Fees

rr_ManagementFeesOverAssets

1.14%

^[1],[2]

Distribution and Service (12b-1) Fees

rr_DistributionAndService12b1FeesOverAssets

^[1]

Other Expenses

rr_OtherExpensesOverAssets

0.31%

^[1]

Total Annual Fund Operating Expenses

rr_ExpensesOverAssets

1.45%

^[1]

1 Year

rr_ExpenseExampleYear01

148

3 Years

rr_ExpenseExampleYear03

459

5 Years

rr_ExpenseExampleYear05

792

10 Years

rr_ExpenseExampleYear10

1,735

1 Year

rr_ExpenseExampleNoRedemptionYear01

148

3 Years

rr_ExpenseExampleNoRedemptionYear03

459

5 Years

rr_ExpenseExampleNoRedemptionYear05

792

10 Years

rr_ExpenseExampleNoRedemptionYear10

1,735

Eaton Vance Worldwide Health Sciences Fund | Class R

Risk/Return:

rr_RiskReturnAbstract

Trading Symbol

dei_TradingSymbol

ERHSX

Maximum Sales Charge (Load) (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum Deferred Sales Charge (Load) (as a percentage of the lower of net asset value at purchase or redemption)

rr_MaximumDeferredSalesChargeOverOfferingPrice

none

Management Fees

rr_ManagementFeesOverAssets

1.14%

^[1],[2]

Distribution and Service (12b-1) Fees

rr_DistributionAndService12b1FeesOverAssets

0.50%

^[1]

Other Expenses

rr_OtherExpensesOverAssets

0.31%

^[1]

Total Annual Fund Operating Expenses

rr_ExpensesOverAssets

1.95%

^[1]

1 Year

rr_ExpenseExampleYear01

198

3 Years

rr_ExpenseExampleYear03

612

5 Years

rr_ExpenseExampleYear05

1,052

10 Years

rr_ExpenseExampleYear10

2,275

1 Year

rr_ExpenseExampleNoRedemptionYear01

198

3 Years

rr_ExpenseExampleNoRedemptionYear03

612

5 Years

rr_ExpenseExampleNoRedemptionYear05

1,052

10 Years

rr_ExpenseExampleNoRedemptionYear10

2,275

[1] Expenses in the table above and the Example below reflect the expenses of the Fund and the Portfolio.

[2] Management Fees have been restated to reflect the terms of an Amended and Restated Investment Advisory Agreement effective August 1, 2011 and assume that the new Index used for performance fee purposes was in place for the entire performance adjustment period. The restated performance fee adjustment would have increased the effective rate of the basic investment advisory fee of 0.48% by 0.17% for the most recent fiscal year ended August 31, 2011. Restated Management Fees also reflect a fee reduction agreement to the Management Agreement and an Amended and Restated Administrative Services Agreement, both effective May 1, 2012. See page 9 of the Fund's Prospectus for more information about the calculation of the performance fee adjustment.

XML

Document and Entity Information	12 Months Ended
	Jan. 01, 2012
Risk/Return:
Document Type	Other
Document Period End Date	Aug. 31, 2011
Registrant Name	EATON VANCE GROWTH TRUST
Central Index Key	0000102816
Amendment Flag	false
Document Creation Date	Jun. 21, 2012
Document Effective Date	Jun. 21, 2012
Prospectus Date	Jan. 01, 2012

XML

Label	Element	Value
Risk/Return:	rr_RiskReturnAbstract
Registrant Name	dei_EntityRegistrantName	EATON VANCE GROWTH TRUST
Prospectus Date	rr_ProspectusDate	Jan. 01, 2012
Document Creation Date	dei_DocumentCreationDate	Jun. 21, 2012